| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-87061-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-87062-25ul | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Alkaline Phosphatase | NBP1-97220 | |||
| Biotin | NBP1-97078 | |||
| FITC | NBP1-96789 | |||
| HRP | NBP1-97073 | |||
| Rhodamine | NBP1-96790 | |||
| Texas Red | NBP1-97079 | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Biotin | NBP1-96836 | |||
| FITC | NBP1-96884 | |||
| HRP | NBP1-96964 | |||
| Rhodamine | NBP1-96885 | |||
| Texas Red | NBP1-96835 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP1-96964 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-45064 | |||
| Azide and BSA Free | NBP2-34648-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-83409-25ul | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Alkaline Phosphatase | NBP1-97219 | |||
| Biotin | NBP1-96855 | |||
| FITC | NBP1-96880 | |||
| HRP | NBP1-97066 | |||
| Rhodamine | NBP1-96882 | |||
| Texas Red | NBP1-96854 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70933 | |||
![Immunocytochemistry/Immunofluorescence: 15-PGDH/HPGD Antibody [NBP1-87061] - Staining of human cell line U-2 OS shows localization to cytosol. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/15-PGDH-HPGD-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-87061-img0009.jpg "Immunocytochemistry/Immunofluorescence: 15-PGDH/HPGD Antibody [NBP1-87061] - Staining of human cell line U-2 OS shows localization to cytosol. Antibody staining is shown in green.")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: 15-PGDH/HPGD Antibody [NBP1-87061] - Analysis in human urinary bladder and skeletal muscle tissues. Corresponding HPGD RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/15-PGDH-HPGD-Antibody-Immunohistochemistry-Paraffin-NBP1-87061-img0017.jpg)
![Immunohistochemistry-Paraffin: 15-PGDH/HPGD Antibody [NBP1-87061] - Staining of human urinary bladder shows strong cytoplasmic positivity in urothelial cells.](http://images.novusbio.com/fullsize/15-PGDH-HPGD-Antibody-Immunohistochemistry-Paraffin-NBP1-87061-img0021.jpg)
![Immunohistochemistry-Paraffin: 15-PGDH/HPGD Antibody [NBP1-87061] - Staining of human skeletal muscle shows no positivity in myocytes as expected.](http://images.novusbio.com/fullsize/15-PGDH-HPGD-Antibody-Immunohistochemistry-Paraffin-NBP1-87061-img0019.jpg)
![Immunohistochemistry-Paraffin: 15-PGDH/HPGD Antibody [NBP1-87061] - Staining of human placenta shows moderate cytoplasmic positivity in trophoblastic cells.](http://images.novusbio.com/fullsize/15-PGDH-HPGD-Antibody-Immunohistochemistry-Paraffin-NBP1-87061-img0018.jpg)
![Immunohistochemistry-Paraffin: 15-PGDH/HPGD Antibody [NBP1-87061] - Staining of human stomach shows strong cytoplasmic positivity in glandular cells.](http://images.novusbio.com/fullsize/15-PGDH-HPGD-Antibody-Immunohistochemistry-Paraffin-NBP1-87061-img0020.jpg)
![Immunohistochemistry-Paraffin: 15-PGDH/HPGD Antibody [NBP1-87062] - Analysis in human urinary bladder and cerebral cortex tissues using NBP1-87062 antibody. Corresponding HPGD RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/15-PGDH-HPGD-Antibody-Immunohistochemistry-Paraffin-NBP1-87062-img0016.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: 15-PGDH/HPGD Antibody [NBP1-87062] - Analysis in human urinary bladder and cerebral cortex tissues using NBP1-87062 antibody. Corresponding HPGD RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: 15-PGDH/HPGD Antibody [NBP1-87062] - Staining of human stomach shows moderate to strong cytoplasmic and membranous positivity in glandular cells.](http://images.novusbio.com/fullsize/15-PGDH-HPGD-Antibody-Immunohistochemistry-Paraffin-NBP1-87062-img0018.jpg)
![Immunohistochemistry-Paraffin: 15-PGDH/HPGD Antibody [NBP1-87062] - Staining of human placenta shows moderate to strong cytoplasmic positivity in trophoblastic cells.](http://images.novusbio.com/fullsize/15-PGDH-HPGD-Antibody-Immunohistochemistry-Paraffin-NBP1-87062-img0017.jpg)
![Immunohistochemistry-Paraffin: 15-PGDH/HPGD Antibody [NBP1-87062] - Staining of human cerebral cortex shows no positivity in neurons as expected.](http://images.novusbio.com/fullsize/15-PGDH-HPGD-Antibody-Immunohistochemistry-Paraffin-NBP1-87062-img0019.jpg)
![Western Blot: 15-PGDH/HPGD Antibody [NBP1-87062] - Analysis in human cell line RT-4 and human cell line U-251 MG.](http://images.novusbio.com/fullsize/15-PGDH-HPGD-Antibody-Western-Blot-NBP1-87062-img0014.jpg)
![Flow Cytometry: Mouse IgG Isotype Control [NBP1-97019]](http://images.novusbio.com/fullsize/Mouse-IgG-Isotype-Control-Flow-Cytometry-NBP1-97019-img0004.jpg "Flow Cytometry: Mouse IgG Isotype Control [NBP1-97019]")
![SDS-Page: Mouse IgG Isotype Control [NBP1-97019] - Lane 1: 5 uL Opal Prestained Marker Lane 2: Reduced Mouse IgG Whole Molecule (BULK ORDER) Lane 3: Reduced Mouse F(c) Fragment Lane 4: Reduced Mouse F(ab) Fragment Lane 5: Mouse IgM Kappa Myeloma Protein Load: 1 ug per lane. Predicted/Observed size: IgG at 50 and 25 kDa; F(c) at 25 kDa; F(ab) at 25 kDa; IgM K at 70 and 23 kDa. Observed F(c) Fragment migrates slightly higher.](http://images.novusbio.com/fullsize/Mouse-IgG-Isotype-Control-SDS-Page-NBP1-97019-img0003.jpg)
![SDS-Page: Mouse IgG Isotype Control [NBP1-97019] - SDS-Page of Mouse IgG Isotype control. Lane 1: Mouse IgG reduced. Lane 2: Molecular Weight Marker. Lane 3: Mouse IgG non-reduced. Load: 1 ug per lane.Predicted/Observed size (non-reduced): 160 kDa, 160 kDa.Predicted/Observed size (reduced): 55 and 28 kDa, 55 and 28 kDa.](http://images.novusbio.com/fullsize/Mouse-IgG-Isotype-Control-SDS-Page-NBP1-97019-img0005.jpg)
![Immunocytochemistry/Immunofluorescence: Guinea Pig IgG Isotype Control [NBP1-97036] - Guinea Pig and Mouse IgG control. Image collected and cropped by CiteAb from the following publication (mdpi.com/2073-4409/8/11/1369), licensed under a CC-BY license.](http://images.novusbio.com/fullsize/Guinea-Pig-IgG-Isotype-Control-Immunocytochemistry-Immunofluorescence-NBP1-97036-img0002.jpg "Immunocytochemistry/Immunofluorescence: Guinea Pig IgG Isotype Control [NBP1-97036] - Guinea Pig and Mouse IgG control. Image collected and cropped by CiteAb from the following publication (mdpi.com/2073-4409/8/11/1369), licensed under a CC-BY license.")
![SDS-Page: Guinea Pig IgG Isotype Control [NBP1-97036] - Lane 1: Guinea Pig IgG - Non-reduced. Lane 2: Guinea Pig IgG - Reduced. Load: 1.0 ug per lane. Predicted/Observed size: 25 & 55 kDa - Reduced, 160 kDa - Non-reduced for IgG whole molecule. Other band(s): None.](http://images.novusbio.com/fullsize/Guinea-Pig-IgG-Isotype-Control-SDS-Page-NBP1-97036-img0001.jpg)
![Western Blot: GAD2/GAD65 Antibody [NBP1-33284] - Various tissue extracts (50 ug) were separated by 7.5% SDS-PAGE, and the membrane was blotted with GAD65 antibody diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/GAD2-GAD65-Antibody-Western-Blot-NBP1-33284-img0012.jpg "Western Blot: GAD2/GAD65 Antibody [NBP1-33284] - Various tissue extracts (50 ug) were separated by 7.5% SDS-PAGE, and the membrane was blotted with GAD65 antibody diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.")
![Immunohistochemistry-Paraffin: GAD2/GAD65 Antibody [NBP1-33284] - RT2 xenograft. GAD65 antibody dilution: 1:500. Antigen Retrieval: Trilogy™ (EDTA based, pH 8.0) buffer, 15min.](http://images.novusbio.com/fullsize/GAD2-GAD65-Antibody-Immunohistochemistry-Paraffin-NBP1-33284-img0010.jpg)
![Immunocytochemistry/Immunofluorescence: GAD2/GAD65 Antibody [NBP1-33284] - Paraformaldehyde-fixed HeLa, using GAD65 antibody (Green) at 1:500 dilution. Alpha-tubulin filaments were labeled with Red at 1:2500.](http://images.novusbio.com/fullsize/GAD2-GAD65-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-33284-img0008.jpg)
![GAD65 antibody detects GAD65 protein by immunofluorescent analysis.Sample: DIV9 rat E18 primary hippocampal neuron cells were fixed in 4% paraformaldehyde at RT for 15 min.Green: GAD65 stained by GAD65 antibody (NBP1-33284) diluted at 1:500.Red: beta Tubulin 3/ Tuj1, stained by beta Tubulin 3/ Tuj1 antibody [GT11710] diluted at 1:500.Blue: Fluoroshield with DAPI .](http://images.novusbio.com/fullsize/nbp1-33284_rabbit-polyclonal-gad2-gad65-antibody-immunocytochemistry-immunofluorescence-2611202518365910.jpg)
![Immunohistochemistry: CD52 Antibody (Campath-1H) [NBP2-75896] - Anti-CD52 staining of formaldehyde fixed paraffin embedded rat thymus tissue, at 40x magnification. The human IgG1-chimeric version of Campath-1H (NBP2-75896) was used to stain samples at a concentration of 5 ug/ml.](http://images.novusbio.com/fullsize/CD52-Antibody-Campath-1H-Immunohistochemistry-NBP2-75896-img0006.jpg "Immunohistochemistry: CD52 Antibody (Campath-1H) [NBP2-75896] - Anti-CD52 staining of formaldehyde fixed paraffin embedded rat thymus tissue, at 40x magnification. The human IgG1-chimeric version of Campath-1H (NBP2-75896) was used to stain samples at a concentration of 5 ug/ml.")
![Immunohistochemistry: CD52 Antibody (Campath-1H) [NBP2-75896] - Formalin fixed human thyroid cancer slices were were stained with a NBP2-75896 at 5 ug/ml.](http://images.novusbio.com/fullsize/CD52-Antibody-Campath-1H-Immunohistochemistry-NBP2-75896-img0003.jpg)
![Immunohistochemistry: CD52 Antibody (Campath-1H) [NBP2-75896] - Anti-CD52 staining of formaldehyde fixed paraffin embedded rat epididymis tissue, at 40x magnification. The human IgG1-chimeric version of Campath-1H (NBP2-75896) was used to stain samples at a concentration of 5 ug/ml.](http://images.novusbio.com/fullsize/CD52-Antibody-Campath-1H-Immunohistochemistry-NBP2-75896-img0004.jpg)
![Immunohistochemistry: CD52 Antibody (Campath-1H) [NBP2-75896] - Anti-CD52 staining of formaldehyde fixed paraffin embedded rat spleen tissue, at 40x magnification. The human IgG1-chimeric version of Campath-1H (NBP2-75896) was used to stain samples at a concentration of 5 ug/ml.](http://images.novusbio.com/fullsize/CD52-Antibody-Campath-1H-Immunohistochemistry-NBP2-75896-img0005.jpg)
![Immunofluorescence: CD52 Antibody (Campath-1H) [NBP2-75896] - Formaldehyde-fixed rat thymus slices were stained with NBP2-75896 at 5 ug/ml and detected with a FITC-conjugated secondary antibody.](http://images.novusbio.com/fullsize/CD52-Antibody-Campath-1H-Immunofluorescence-NBP2-75896-img0002.jpg)
![Western Blot: Vitronectin Antibody [NBP2-20866] - Proteomics analysis of losartan-mediated reversion of early fibrotic RDEB changes.Bar graph show abundance of representative proteins normalized by losartan treatment. Mean +/- S.E.M. (LFQ intensity) of groups of individual mice (wild-type, untreated, & losartan-treated C7-hypomorphic mice). Unpaired t-test calculated significance. Abundance of Lrg1: *P-value C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.022; abundance of serpin f2: **P-value untreated C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.0084; abundance of vitronectin: **P-value untreated C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.0094. Western blots of skin lysates from wild-type, untreated C7-hypomorphic, & 7-week losartan-treated C7-hypomorphic mice not used for proteomics. Image collected & cropped by CiteAb from the following publication (www.onlinelibrary.wiley.com/doi/10.15252/emmm.201505061) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-Western-Blot-NBP2-20866-img0009.jpg "<b>Biological Strategies Validation. </b>Western Blot: Vitronectin Antibody [NBP2-20866] - Proteomics analysis of losartan-mediated reversion of early fibrotic RDEB changes.Bar graph show abundance of representative proteins normalized by losartan treatment. Mean +/- S.E.M. (LFQ intensity) of groups of individual mice (wild-type, untreated, & losartan-treated C7-hypomorphic mice). Unpaired t-test calculated significance. Abundance of Lrg1: *P-value C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.022; abundance of serpin f2: **P-value untreated C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.0084; abundance of vitronectin: **P-value untreated C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.0094. Western blots of skin lysates from wild-type, untreated C7-hypomorphic, & 7-week losartan-treated C7-hypomorphic mice not used for proteomics. Image collected & cropped by CiteAb from the following publication (www.onlinelibrary.wiley.com/doi/10.15252/emmm.201505061) licensed under a CC-BY license.")
![<b>Biological Strategies Validation. </b>Immunohistochemistry-Paraffin: Vitronectin Antibody [NBP2-20866] - Vitronectin antibody detects Vitronectin protein by immunohistochemical analysis. Sample: Paraffin-embedded human lung cancer. Vitronectin stained by Vitronectin antibody diluted at 1:1000.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-Immunohistochemistry-Paraffin-NBP2-20866-img0008.jpg)
![Immunohistochemistry-Paraffin: Vitronectin Antibody [NBP2-20866] - Human colon carcinoma, using Vitronectin antibody at 1:500 dilution. Antigen Retrieval: Trilogy™ (EDTA based, pH 8.0) buffer, 15min.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-Immunohistochemistry-Paraffin-NBP2-20866-img0003.jpg)
![Western Blot: Vitronectin Antibody [NBP2-20866] - HepG2 whole cell extract and conditioned medium (30 ug) were separated by 10% SDS-PAGE, and the membrane was blotted with Vitronectin antibody (NBP2-20866) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/nbp2-20866_rabbit-polyclonal-vitronectin-antibody-910202420104489.jpg)
![Immunocytochemistry/Immunofluorescence: IgG Antibody (IG266) [NBP2-34250] - Multiple myeloma LP-1 and H929 cells stained with NBP2-34250 antibody. Image from verified customer review.](http://images.novusbio.com/fullsize/IgG-Antibody-IG266-Immunocytochemistry-Immunofluorescence-NBP2-34250-img0004.jpg "Immunocytochemistry/Immunofluorescence: IgG Antibody (IG266) [NBP2-34250] - Multiple myeloma LP-1 and H929 cells stained with NBP2-34250 antibody. Image from verified customer review.")
![Immunohistochemistry-Paraffin: IgG Antibody (IG266) [NBP2-34250] - Formalin-fixed, paraffin embedded human Tonsil stained with IgG Monoclonal Antibody (IG266).](http://images.novusbio.com/fullsize/IgG-Antibody-IG266-Immunohistochemistry-Paraffin-NBP2-34250-img0003.jpg)
![Protein Array: IgG Antibody (IG266) [NBP2-34250] - Analysis of Protein Array containing more than 19,000 full-length human proteins using Anti-IgG Antibody (IG266). Z- and S- Score: The Z-score represents the strength of a signal that a monoclonal antibody (Monoclonal Antibody) (in combination with a fluorescently-tagged anti-IgG secondary antibody) produces when binding to a particular protein on the HuProt(TM) array. Z-scores are described in units of standard deviations (SD's) above the mean value of all signals generated on that array. If targets on HuProt(TM) are arranged in descending order of the Z-score, the S-score is the difference (also in units of SD's) between the Z-score. S-score therefore represents the relative target specificity of a Monoclonal Antibody to its intended target. A Monoclonal Antibody is considered to specific to its intended target, if the Monoclonal Antibody has an S-score of at least 2.5.](http://images.novusbio.com/fullsize/nbp2-34250_mouse-monoclonal-igg-antibody-ig266-177202495944.jpg)
![Immunohistochemistry-Paraffin: Hyaluronidase 1/HYAL1 Antibody [NBP1-83409] - Staining of human liver shows moderate to strong granular cytoplasmic positivity in hepatocytes.](http://images.novusbio.com/fullsize/Hyaluronidase-1-HYAL1-Antibody-Immunohistochemistry-Paraffin-NBP1-83409-img0006.jpg "Immunohistochemistry-Paraffin: Hyaluronidase 1/HYAL1 Antibody [NBP1-83409] - Staining of human liver shows moderate to strong granular cytoplasmic positivity in hepatocytes.")
![Immunohistochemistry-Paraffin: Hyaluronidase 1/HYAL1 Antibody [NBP1-83409] - Staining of human kidney shows moderate to strong granular cytoplasmic positivity in cells in tubules.](http://images.novusbio.com/fullsize/Hyaluronidase-1-HYAL1-Antibody-Immunohistochemistry-Paraffin-NBP1-83409-img0004.jpg)
![Immunohistochemistry-Paraffin: Hyaluronidase 1/HYAL1 Antibody [NBP1-83409] - Staining of human gallbladder shows moderate to strong granular cytoplasmic positivity in glandular cells.](http://images.novusbio.com/fullsize/Hyaluronidase-1-HYAL1-Antibody-Immunohistochemistry-Paraffin-NBP1-83409-img0005.jpg)
![Immunohistochemistry-Paraffin: Hyaluronidase 1/HYAL1 Antibody [NBP1-83409] - Staining of human tonsil shows very weak positivity as expected.](http://images.novusbio.com/fullsize/Hyaluronidase-1-HYAL1-Antibody-Immunohistochemistry-Paraffin-NBP1-83409-img0007.jpg)
![Western Blot: Human IgG Isotype Control [NBP1-97043] - SDS-PAGE of Human IgG.Lane 1: Reduced Human IgG.Lane 2: 5uL OPAL Pre-stained MarkerLane 3: Non-reduced Human IgG.Load: 1ug per lane.Predicted/Observed size: Non-reduced at 180-245 kDa, Reduced at 55, 25 kDa.](http://images.novusbio.com/fullsize/Human-IgG-Isotype-Control-Western-Blot-NBP1-97043-img0003.jpg "Western Blot: Human IgG Isotype Control [NBP1-97043] - SDS-PAGE of Human IgG.Lane 1: Reduced Human IgG.Lane 2: 5uL OPAL Pre-stained MarkerLane 3: Non-reduced Human IgG.Load: 1ug per lane.Predicted/Observed size: Non-reduced at 180-245 kDa, Reduced at 55, 25 kDa.")
![SDS-Page: Human IgG Isotype Control [NBP1-97043] - SDS-PAGE of Human IgG Isotype control.Lane 1: Reduced Human IgG Isotype control.Lane 2: 5uL OPAL Pre-stained Marker. Load: 1ug per lane.Predicted/Observed size: Non-reduced at 180-245 kDa , Reduced at 55, 25 kDa.](http://images.novusbio.com/fullsize/Human IgG Isotype Control-SDS-Page-NBP1-97043-img0004.jpg)
![Western Blot: 15-PGDH/HPGD Antibody (OTI2C10) [NBP2-00490] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY 15-PGDH (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-15-PGDH.](http://images.novusbio.com/fullsize/15-PGDH-Antibody-2C10-Western-Blot-NBP2-00490-img0004.jpg "Western Blot: 15-PGDH/HPGD Antibody (OTI2C10) [NBP2-00490] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY 15-PGDH (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-15-PGDH.")
![Immunohistochemistry-Paraffin: 15-PGDH/HPGD Antibody (OTI2C10) [NBP2-00490] - Staining of Human bladder tissue using anti-15-PGDH mouse monoclonal antibody.](http://images.novusbio.com/fullsize/15-PGDH-Antibody-2C10-Immunohistochemistry-Paraffin-NBP2-00490-img0006.jpg)
![Flow Cytometry: 15-PGDH/HPGD Antibody (OTI2C10) [NBP2-00490] - HEK293T cells transfected with either overexpression plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-15-PGDH antibody, and then analyzed by flow cytometry.](http://images.novusbio.com/fullsize/15-PGDH-Antibody-2C10-Flow-Cytometry-NBP2-00490-img0003.jpg)
![Immunohistochemistry-Paraffin: 15-PGDH/HPGD Antibody (OTI2C10) [NBP2-00490] - Staining of Adenocarcinoma of Human endometrium tissue using anti-15-PGDH mouse monoclonal antibody.](http://images.novusbio.com/fullsize/15-PGDH-Antibody-2C10-Immunohistochemistry-Paraffin-NBP2-00490-img0005.jpg)
![Flow Cytometry: 15-PGDH/HPGD Antibody (OTI2C10) [NBP2-00490] - Analysis of Hela cells, using anti-15-PGDH antibody, (Red), compared to a nonspecific negative control antibody (Blue).](http://images.novusbio.com/fullsize/15-PGDH-Antibody-2C10-Flow-Cytometry-NBP2-00490-img0001.jpg)
![Flow Cytometry: 15-PGDH/HPGD Antibody (OTI2C10) [NBP2-00490] - Analysis of Jurkat cells, using anti-15-PGDH antibody, (Red), compared to a nonspecific negative control antibody (Blue).](http://images.novusbio.com/fullsize/15-PGDH-Antibody-2C10-Flow-Cytometry-NBP2-00490-img0002.jpg)
![Western Blot: 15-PGDH/HPGD Antibody (OTI2C10) - Azide and BSA Free [NBP2-70933] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY 15-PGDH (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-15-PGDH.](http://images.novusbio.com/fullsize/15-PGDH-HPGD-Antibody-OTI2C10-Azide-and-BSA-Free-Western-Blot-NBP2-70933-img0002.jpg "Western Blot: 15-PGDH/HPGD Antibody (OTI2C10) - Azide and BSA Free [NBP2-70933] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY 15-PGDH (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-15-PGDH.")
![Immunohistochemistry: 15-PGDH/HPGD Antibody (OTI2C10) - Azide and BSA Free [NBP2-70933] - Staining of Human bladder tissue using anti-15-PGDH mouse monoclonal antibody.](http://images.novusbio.com/fullsize/15-PGDH-HPGD-Antibody-OTI2C10-Azide-and-BSA-Free-Immunohistochemistry-NBP2-70933-img0006.jpg)
![Flow Cytometry: 15-PGDH/HPGD Antibody (OTI2C10) - Azide and BSA Free [NBP2-70933] - HEK293T cells transfected with either overexpression plasmid (Red) or empty vector control plasmid (Blue) were immunostaining by anti-15-PGDH antibody, and then analyzed by flow cytometry.](http://images.novusbio.com/fullsize/15-PGDH-HPGD-Antibody-OTI2C10-Azide-and-BSA-Free-Flow-Cytometry-NBP2-70933-img0005.jpg)
![Immunohistochemistry: 15-PGDH/HPGD Antibody (OTI2C10) - Azide and BSA Free [NBP2-70933] - Staining of Adenocarcinoma of Human endometrium tissue using anti-15-PGDH mouse monoclonal antibody.](http://images.novusbio.com/fullsize/15-PGDH-HPGD-Antibody-OTI2C10-Azide-and-BSA-Free-Immunohistochemistry-NBP2-70933-img0007.jpg)
![Flow Cytometry: 15-PGDH/HPGD Antibody (OTI2C10) - Azide and BSA Free [NBP2-70933] - Analysis of Hela cells, using anti-15-PGDH antibody, (Red), compared to a nonspecific negative control antibody (Blue).](http://images.novusbio.com/fullsize/15-PGDH-HPGD-Antibody-OTI2C10-Azide-and-BSA-Free-Flow-Cytometry-NBP2-70933-img0003.jpg)
![Flow Cytometry: 15-PGDH/HPGD Antibody (OTI2C10) - Azide and BSA Free [NBP2-70933] - Analysis of Jurkat cells, using anti-15-PGDH antibody, (Red), compared to a nonspecific negative control antibody (Blue).](http://images.novusbio.com/fullsize/15-PGDH-HPGD-Antibody-OTI2C10-Azide-and-BSA-Free-Flow-Cytometry-NBP2-70933-img0004.jpg)